C4 Therapeutics, Inc. CCCC

Set alert

Price alert · CCCC

All alert types
3.37 USD +0.07 +2.12%

At close · Oct 30

3.28 -0.09 -2.77%

After hours · Oct 30, 4:41 PM ET

Bid
3.37 × 2
Ask
3.38 × 30
3.21 Day range 3.38
1.71 52-week range 4.67
YTD
+76.44%
1 year
+36.99%
Open
3.23
Prev close
3.30
Mkt cap
414.59M
Vol
2.35M
Avg vol
2.42M
EPS
-0.91
P/E
0.00
Div yield
0.00%
More statistics
Low
3.21
High
3.38
Forward P/E
-2.37
Beta
3.06
Short ratio
7.10
Inst. own
91.47%
Dividend
0.00
Ex-div date
Earnings
Aug 1, 2024
50-d avg
5.06
200-d avg
5.96
1y target
15.00

MAX chart

Chart tools
Interval

Events in this range
  • Feb 22, 2024Earnings: -0.68; estimate -0.67; surprise -1.49%
  • Feb 26, 2024Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • May 8, 2024Earnings: -0.41; estimate -0.41; surprise 0%
  • May 8, 2024Earnings: —; estimate -0.41; surprise —%
  • May 9, 2024Rating: Stifel · Buy → Buy
  • May 9, 2024Rating: Wells Fargo · Equal-Weight → Equal-Weight
  • Aug 1, 2024Earnings: -0.26; estimate -0.37; surprise 29.73%
  • Aug 1, 2024Earnings: —; estimate -0.37; surprise —%
  • Aug 6, 2024Rating: BMO Capital · Outperform → Outperform
  • Oct 31, 2024Earnings: -0.35; estimate -0.4; surprise 12.5%
  • Nov 18, 2024Rating: Stephens & Co. · — → Equal-Weight
  • Dec 19, 2024Rating: Wells Fargo · Equal-Weight → Overweight
Signals (102)
NameDateAgo
SMA: BullishOct 26, 20266 days ago
SMA: BearishSep 14, 20261 month ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 10, 20262 months ago
MACD: Sell SignalJul 20, 20263 months ago
SMA: BearishJul 13, 20263 months ago
RSI: OverboughtMay 25, 20265 months ago
SMA: BullishFeb 23, 20268 months ago
MACD: Buy SignalFeb 23, 20268 months ago
SMA: BullishFeb 16, 20268 months ago
SMA: BearishDec 15, 202510 months ago
MACD: Sell SignalDec 15, 202510 months ago
SMA: BearishDec 8, 202510 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BearishNov 3, 202512 months ago
SMA: BullishOct 27, 20251 year ago
SMA: BearishSep 22, 20251 year ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 14, 20251 year ago
SMA: BullishJul 7, 20251 year ago
SMA: BearishJun 16, 20251 year ago
SMA: BullishJun 2, 20251 year ago
RSI: OversoldMay 26, 20251 year ago
MACD: Buy SignalMay 19, 20251 year ago
RSI: OversoldMar 3, 20251 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BearishOct 28, 20242 years ago
MACD: Sell SignalOct 28, 20242 years ago
SMA: BearishOct 21, 20242 years ago
SMA: BullishOct 14, 20242 years ago
SMA: BullishOct 14, 20242 years ago
MACD: Buy SignalOct 14, 20242 years ago
MACD: Sell SignalSep 30, 20242 years ago
SMA: BearishSep 23, 20242 years ago
SMA: BullishSep 9, 20242 years ago
SMA: BearishSep 2, 20242 years ago
SMA: BearishAug 26, 20242 years ago
SMA: BullishAug 19, 20242 years ago
MACD: Buy SignalAug 12, 20242 years ago
MACD: Sell SignalAug 5, 20242 years ago
MACD: Buy SignalJul 29, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishMay 13, 20242 years ago
MACD: Sell SignalApr 8, 20242 years ago
SMA: BearishApr 1, 20242 years ago
RSI: OverboughtFeb 12, 20242 years ago
RSI: OverboughtJan 1, 20242 years ago
SMA: BullishDec 11, 20232 years ago
SMA: BullishDec 11, 20232 years ago
MACD: Buy SignalNov 6, 20232 years ago
MACD: Sell SignalOct 23, 20233 years ago
RSI: OversoldOct 23, 20233 years ago
MACD: Buy SignalOct 16, 20233 years ago
MACD: Sell SignalOct 2, 20233 years ago
RSI: OversoldSep 18, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BullishJul 3, 20233 years ago
SMA: BearishJun 19, 20233 years ago
SMA: BullishMay 29, 20233 years ago
MACD: Buy SignalMay 8, 20233 years ago
RSI: OversoldApr 24, 20233 years ago
RSI: OversoldMar 27, 20233 years ago
MACD: Sell SignalFeb 27, 20233 years ago
SMA: BearishJan 30, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishNov 21, 20223 years ago
SMA: BearishNov 21, 20223 years ago
SMA: BullishNov 7, 20223 years ago
SMA: BullishNov 7, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishSep 5, 20224 years ago
SMA: BearishAug 29, 20224 years ago
SMA: BullishJun 27, 20224 years ago
MACD: Buy SignalJun 20, 20224 years ago
SMA: BearishApr 4, 20224 years ago
MACD: Sell SignalApr 4, 20224 years ago
RSI: OversoldApr 4, 20224 years ago
MACD: Buy SignalMar 28, 20224 years ago
SMA: BullishMar 14, 20224 years ago
RSI: OversoldFeb 14, 20224 years ago
RSI: OversoldJan 17, 20224 years ago
SMA: BearishNov 15, 20214 years ago
MACD: Sell SignalOct 11, 20215 years ago
SMA: BearishOct 4, 20215 years ago
MACD: Buy SignalAug 30, 20215 years ago
SMA: BullishAug 16, 20215 years ago
SMA: BullishAug 9, 20215 years ago
SMA: BearishAug 2, 20215 years ago
SMA: BearishAug 2, 20215 years ago
MACD: Sell SignalAug 2, 20215 years ago
MACD: Buy SignalJul 26, 20215 years ago
SMA: BullishMay 17, 20215 years ago
SMA: BullishMay 17, 20215 years ago
SMA: BearishMar 15, 20215 years ago

Financial health

Altman Z-Score

-0.97 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E -1.5×
FY 2018: -24.0×FY 2019: -32.3×FY 2020: -21.5×FY 2021: -17.7×FY 2022: -2.3×FY 2023: -2.1×FY 2024: -2.4×FY 2025: -1.5×
FY 2018 5y median -2.3× FY 2025
P/S 4.4×
FY 2018: 19.5×FY 2019: 51.2×FY 2020: 43.0×FY 2021: 32.4×FY 2022: 9.3×FY 2023: 13.5×FY 2024: 7.0×FY 2025: 4.4×
FY 2018 5y median 9.3× FY 2025
P/B 0.6×
FY 2018: -4.7×FY 2019: -9.8×FY 2020: 5.1×FY 2021: 3.8×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 1.2×FY 2025: 0.6×
FY 2018 5y median 1.1× FY 2025
P/FCF -1.6×
FY 2018: -19.2×FY 2019: 20.2×FY 2020: -21.0×FY 2021: -16.8×FY 2022: -2.6×FY 2023: -2.6×FY 2024: -3.8×FY 2025: -1.6×
FY 2018 5y median -2.6× FY 2025
EV/EBITDA -1.4×
FY 2018: -23.5×FY 2019: -32.1×FY 2020: -21.5×FY 2021: -18.1×FY 2022: -2.8×FY 2023: -1.8×FY 2024: -2.5×FY 2025: -1.4×
FY 2018 5y median -2.5× FY 2025
EV/Sales 4.0×
FY 2018: 18.3×FY 2019: 47.7×FY 2020: 38.2×FY 2021: 31.7×FY 2022: 11.1×FY 2023: 10.8×FY 2024: 7.3×FY 2025: 4.0×
FY 2018 5y median 10.8× FY 2025
FCF Yield -62.7%
FY 2018: -5.2%FY 2019: 5.0%FY 2020: -4.8%FY 2021: -6.0%FY 2022: -38.7%FY 2023: -38.7%FY 2024: -26.2%FY 2025: -62.7%
FY 2018 5y median -38.7% FY 2025

Profitability

Gross Margin 77.8%
FY 2018: -47.7%FY 2019: 100.0%FY 2020: -136.3%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 62.7%FY 2024: 100.0%FY 2025: 77.8%
FY 2018 5y median 100.0% FY 2025
Operating Margin -290.7%
FY 2018: -84.6%FY 2019: -165.8%FY 2020: -182.1%FY 2021: -179.4%FY 2022: -416.6%FY 2023: -669.8%FY 2024: -336.1%FY 2025: -290.7%
FY 2018 5y median -336.1% FY 2025
Net Margin -292.1%
FY 2018: -81.1%FY 2019: -159.5%FY 2020: -199.8%FY 2021: -183.2%FY 2022: -412.2%FY 2023: -638.3%FY 2024: -296.0%FY 2025: -292.1%
FY 2018 5y median -296.0% FY 2025
ROE -40.9%
FY 2018: 19.7%FY 2019: 30.5%FY 2020: -23.6%FY 2021: -21.5%FY 2022: -44.3%FY 2023: -53.8%FY 2024: -48.8%FY 2025: -40.9%
FY 2018 5y median -44.3% FY 2025
ROIC -31.4%
FY 2018: -13.3%FY 2019: -41.5%FY 2020: -16.9%FY 2021: -18.0%FY 2022: -32.9%FY 2023: -41.0%FY 2024: -38.6%FY 2025: -31.4%
FY 2018 5y median -32.9% FY 2025
ROA -29.2%
FY 2018: -10.7%FY 2019: -28.8%FY 2020: -16.6%FY 2021: -16.6%FY 2022: -29.8%FY 2023: -35.2%FY 2024: -30.1%FY 2025: -29.2%
FY 2018 5y median -29.8% FY 2025

Growth (YoY)

Revenue 1.0%
FY 2018: 0.0%FY 2019: 10.4%FY 2020: 55.3%FY 2021: 37.9%FY 2022: -32.1%FY 2023: -33.3%FY 2024: 71.4%FY 2025: 1.0%
FY 2018 FY 2025
Operating Income 12.6%
FY 2018: 0.0%FY 2019: -116.3%FY 2020: -70.5%FY 2021: -35.9%FY 2022: -57.7%FY 2023: -7.3%FY 2024: 14.0%FY 2025: 12.6%
FY 2018 FY 2025
EPS (diluted) 16.4%
FY 2018: 0.0%FY 2019: 25.5%FY 2020: -94.9%FY 2021: -18.2%FY 2022: -44.0%FY 2023: -1.9%FY 2024: 43.1%FY 2025: 16.4%
FY 2018 FY 2025
Free Cash Flow -52.0%
FY 2018: 0.0%FY 2019: 375.9%FY 2020: -225.1%FY 2021: -30.0%FY 2022: -26.3%FY 2023: 2.6%FY 2024: 39.8%FY 2025: -52.0%
FY 2018 FY 2025

Financial Health

Current Ratio 7.8×
FY 2018: 5.2×FY 2019: 2.9×FY 2020: 8.7×FY 2021: 6.4×FY 2022: 6.5×FY 2023: 6.3×FY 2024: 5.7×FY 2025: 7.8×
FY 2018 5y median 6.4× FY 2025
Quick Ratio 7.8×
FY 2018: 5.2×FY 2019: 2.9×FY 2020: 8.7×FY 2021: 6.4×FY 2022: 7.8×FY 2023: 6.3×FY 2024: 5.7×FY 2025: 7.8×
FY 2018 5y median 6.4× FY 2025
Debt / Equity 0.2×
FY 2018: -0.2×FY 2019: -0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.2×
FY 2018 5y median 0.3× FY 2025
Net Debt / EBITDA 0.1×
FY 2018: 1.4×FY 2019: 2.4×FY 2020: 2.7×FY 2021: 0.4×FY 2022: -0.5×FY 2023: 0.4×FY 2024: -0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -49.2×FY 2021: -38.3×FY 2022: -58.5×FY 2023: -101×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median -38.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31